Biotechnology Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans’ Trips And More – Awakn Life Sciences (OTC:AWKNF), BetterLife Pharma (OTC:BETRF) Read more
Cannabis Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends – Numinus Wellness (OTC:NUMIF) Read more
Cannabis Psychedelics Reform Update: Missouri’s $10M Budget, Maine’s & Maryland’s Study Groups, Oregon’s Re-Crim And More Read more
Cannabis Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More – Compass Pathways (NASDAQ:CMPS), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline – Compass Pathways (NASDAQ:CMPS), ATAI Life Sciences (NASDAQ:ATAI) Read more
Biotechnology Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression – ATAI Life Sciences (NASDAQ:ATAI) Read more
Biotechnology Podcast: LSD ‘Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics’ Says MindMed’s R. Barrow – Mind Medicine (NASDAQ:MNMD) Read more
Biotechnology Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana’s Research And More – ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Psychedelics Headlines: Substitution Survey, Frank Herbert’s Magic Mushrooms, Celestial Plans And News Review – ATAI Life Sciences (NASDAQ:ATAI), BetterLife Pharma (OTC:BETRF) Read more
Biotechnology Fed Agency Grants $14M To Gilgamesh For Cardiac-Safe Ibogaine Analog Targeting Opioid Use Disorder Read more
